Volume 9, Issue 6 pp. 553-568
Article
Full Access

Validity of contrast hyperemia for clinical assessment of coronary flow reserve: The optimal dose of contrast medium and reproducibility of the technique

Masayoshi Mishima MD

Corresponding Author

Masayoshi Mishima MD

Osaka University School of Medicine, and Osaka Police Hospital, Osaka, Japan

The First Department of Medicine, Osaka University School of Medicine, 1-1-50 Fukushima, Fukushima-ku, Osaka 553, JapanSearch for more papers by this author
Michitoshi Inoue MD

Michitoshi Inoue MD

Osaka University School of Medicine, and Osaka Police Hospital, Osaka, Japan

Search for more papers by this author
Masatsugu Hori MD

Masatsugu Hori MD

Osaka University School of Medicine, and Osaka Police Hospital, Osaka, Japan

Search for more papers by this author
Katsuhiko Tsujioka MD

Katsuhiko Tsujioka MD

Osaka University School of Medicine, and Osaka Police Hospital, Osaka, Japan

Search for more papers by this author
Tsunehiko Kuzuya MD

Tsunehiko Kuzuya MD

Osaka University School of Medicine, and Osaka Police Hospital, Osaka, Japan

Search for more papers by this author
Kazuhisa Kodama MD

Kazuhisa Kodama MD

Osaka University School of Medicine, and Osaka Police Hospital, Osaka, Japan

Search for more papers by this author
Shinsuke Nanto MD

Shinsuke Nanto MD

Osaka University School of Medicine, and Osaka Police Hospital, Osaka, Japan

Search for more papers by this author
Hiroshi Abe MD

Hiroshi Abe MD

Osaka University School of Medicine, and Osaka Police Hospital, Osaka, Japan

Search for more papers by this author
First published: 1983
Citations: 20

Abstract

The dose-response relation of contrast medium-induced hyperemic response in coronary blood flow (contrast hyperemia) was investigated to determine the optimal dose of contrast medium (CM, Urografin-76®) for the assessment of coronary flow reserve in man. The great cardiac venous flow (GCVF) was determined with the continuous thermodilution method during the contrast hyperemia induced by the intracoronary injection of CM of three different doses, ie, 2, 4, and 6 ml/60 kg of body weight, into left coronary artery.

Submaximal coronary vasodilation could be obtained by intracoronary injection of 4 ml of CM with minimal changes in systemic hemodynamics. The contrast hyperemia with this dose of CM was reproducible and also closely correlated with that obtained during pacing-induced angina. Thus, we conclude that the contrast hyperemic technique with intracoronary injection of 4 ml of Urografin-76® could be a reliable method to assess the coronary flow reserve.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.